Return to homepagePandemic Pact

Use of Therapeutic Drug Monitoring (TDM) optimise oral/enteral Hydroxychloroquine dosing in critically ill patients with COVID-19

  • Funded by Medical Research Future Fund (MRFF)
  • Total publications:0 publications
Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $124,114.6

  • Funder

    Medical Research Future Fund (MRFF)

  • Principal Investigator

    Professor Kevin Laupland

  • Research Location

    Australia

  • Lead Research Institution

    Queensland University of Technology

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract